Neuronix

Drug-Free Alzheimer’s Treatment to Seek FDA Approval

Jewish Business News reported that Neuronix just will apply next month for US Food and Drug Administration clearance of its neuroAD system to slow and even reverse progression of Alzheimer's. According to the article Neuronix already has CE clearance for neuroAD in Europe, and the treatment is available in centers across Europe and Asia.